CIDRAP Leadership Forum Infectious Disease BRIEFING August 17, 2016

CIDRAP Leadership Forum Infectious Disease BRIEFING

Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING December 13 th, 2017 CLF BRIEFING HOT TOPICS 1. Influenza (surveillance, vaccine,

CIDRAP Leadership Forum Infectious Disease BRIEFING

Center for Infectious Disease Research and Policy University of Minnesota CIDRAP Leadership Forum Infectious Disease BRIEFING August 22 nd, 2018 CLF BRIEFING HOT TOPICS 1. Ebola 2. Foodborne diseases 3.

Corporate Leadership Forum March Briefing March 11, 2015

Center for Infectious Disease Research and Policy University of Minnesota Corporate Leadership Forum March Briefing March 11, 2015 Michael T. Osterholm, PhD, MPH McKnight Presidential Endowed Chair in

When infections go viral Zika Virus

When infections go viral Zika Virus John Fangman, MD Associate Professor of Medicine (Infectious Diseases) Senior Medical Director of Ambulatory, Medical College Physicians Medical College of Wisconsin

EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?

8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct

VACCINES AND HYGIENE RULES

VACCINES AND HYGIENE RULES Paraguay Bolivia Argentina Paraguay, Argentina and Bolivia are not considered countries "at risk". Better safe than sorry, however, so here are a few important recommendations:

Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017

Outbreak preparedness and the NICD 24-hour hotline a review of calls made to the Hotline, and Outbreak Response Unit, July 2016-June 2017 FIDSSA 2017 Kerrigan McCarthy, Nevashan Govender, Vivien Essel,

Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors:, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto, Vaccine

Module 5: Introduction to Stochastic Epidemic Models with Inference

Module 5: Introduction to Stochastic Epidemic Models with Inference Instructors: Tom Britton, Dept. Mathematics, Stockholm University Ira Longini, Dept. Biostatistics, University of Florida Jonathan Sugimoto,

Arbovirus Surveillance: Present and Future

Arbovirus Surveillance: Present and Future Duane J Gubler, ScD, FAAAS, FIDSA, FASTMH Emeritus Professor Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Chairman, Global Dengue

On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in

Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education

Our Mission. To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers

Our Mission To promote healthy and safe travel by providing medicines, preventive vaccines and health counseling to a diverse group of travelers The Travel Clinic utilizes national and international travel

2/26/2018. Deadliest Enemy: Our War Against Killer Germs

Deadliest Enemy: Our War Against Killer Germs Michael T. Osterholm, PhD, MPH Regents Professor McKnight Presidential Endowed Chair in Public Health Director, Center for Infectious Disease Research & Policy

EC research and innovation strategy and actions

EC research and innovation strategy and actions for preparedness and response to outbreaks IMI Stakeholder Forum 28-29 September 2016 Line Matthiessen Head of Unit E.3 Health Directorate DG Research &

Where is Yellow Fever found?

Yellow Fever Introduction Yellow Fever is an acute viral hemorrhagic disease transmitted by a female mosquito of the Aedes family (Aedes aegypti). Man and monkeys are the only reservoir for this virus.

Classification of Infectious Disease Law in Japan

Classification of Infectious Disease Law in Japan Type 1 (7) Type 2 (7) Type 3 (5) Type 4 (44) Viral Hemorrhagic Fever EVD Lassa Fever CCHF Marburg disease South American Hemorrhagic Fevers Plague Smallpox

Financing international collective action for epidemic & pandemic preparedness

Financing international collective action for epidemic & pandemic preparedness Gavin Yamey MD, MPH Professor of Global Health & Public Policy Director, Center for Policy Impact in Global Health, Duke Global

Preparing for the Unexpected

Centers for Disease Control and Prevention Center for Preparedness and Response Preparing for the Unexpected Stephen C. Redd, MD Rear Admiral, US Public Health Service Director, Center for Preparedness

GAVI S VACCINE INVESTMENT STRATEGY

GAVI S VACCINE INVESTMENT STRATEGY Judith Kallenberg, Head of Policy PDVAC 22 June 2017, Geneva Reach every child www.gavi.org Gavi finances vaccines and immunisation through three routes ($9 Billion in

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Duane J. Gubler, ScD Professor and Founding Director, Signature Research Program in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore AGENDA Other arboviruses with the potential for urban

Arboviruses: A Global Public Health Threat

Arboviruses: A Global Public Health Threat Les Pensières Center for Global Health Veyrier-du-Lac - France 20-22 June 2018 Steering Committee: Duane Gubler Mauricio Lacerda Nogueira Jacques Louis Christopher

How does Gavi make vaccine investment decisions?

How does Gavi make vaccine investment decisions? Judith Kallenberg Global Vaccine and Immunization Research Forum Johannesburg, South-Africa, 16 March 2016 www.gavi.org Vaccine Investment Strategy (VIS)

Experiences on Workforce Development in Other Regions

Experiences on Workforce Development in Other Regions The USA Experience John MacArthur, MD, MPH (EIS 98) Director Thailand MOPH US CDC Collaboration CDC/Southeast Asia Regional Office Epidemic Intelligence

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

Regional Committee for the Eastern Mediterranean Sixty-third session Provisional agenda item 3(c) EM/RC63/INF.DOC 2 Rev.2 September 2016 Introduction Progress report on emerging and re-emerging diseases

Annual Epidemiological Report

August 2018 Annual Epidemiological Report 1 Vectorborne disease in Ireland, 2017 Key Facts 2017: 10 cases of dengue were notified, corresponding to a crude incidence rate (CIR) of 0.2 per 100,000 population

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

What s new in Infectious Diseases Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital None Disclosures Objectives New information in infectious diseases. New diseases and outbreaks.

Understanding and Preparing for Emerging Disease Outbreaks

Understanding and Preparing for Emerging Disease Outbreaks CAPT Ha C. Tang, D.O. US Public Health Service Adjunct Associate Clinical Professor of Dartmouth Medical School, Community/Family Medicine Dept.

Partnerships for Vaccines Forum

October 30, 2018 Partnerships for Vaccines Forum PATH s 40+ years of transformative innovation Steve Davis President & CEO, PATH Photos: PATH/Aaron Joel Santos, PATH/Gabe Bienczycki, PATH/Gabe Bienczycki

WHO: Forum Issue #02 Student Officer Position:

WHO: Topic B Forum : World Health Organization Issue #02 : Topic B: Preparing for a Global Health Crisis Student Officer : Samantha Portillo Position: Chair of the United Nations World Health Organization

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day

INTERfering and Co-Evolving Prevention and Therapy (INTERCEPT) Proposers Day Dr. Jim Gimlett, Program Manager DARPA Biological Technologies Office (BTO) April 28, 2016 Arlington, VA INTERCEPT Agenda INTERCEPT

Multiple Choice Questions

Multiple Choice Questions 1. Which one of the following is not a viral disease? (a) Dengue (b) AIDS (c) Typhoid (d) Influenza 2. Which one of the following is not a bacterial disease? (a) Cholera (b) Tuberculosis

Mosquito-borne virus prevention and control: a global perspective

Mosquito-borne virus prevention and control: a global perspective Chikungunya 2017, Sapienza Universita di Roma 10 November 2017 Erika Garcia Mathematical Epidemiologist World Health Organization Geneva,

Emerging TTIs How Singapore secure its blood supply

Emerging TTIs How Singapore secure its blood supply Ms Sally Lam Acting Division Director I Blood Supply Management I Blood Services Group I Health Sciences Outline Risk Mitigation Strategies to secure

Public health preparedness and response

EXECUTIVE BOARD EB14/9 14nd session January 018 Provisional agenda item 3.3 Public health preparedness and response WHO s work in health emergencies Report by the Director-General 1. This report is submitted

Infectious Diseases Weekly Report. 12 January 2018 / Number 1. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 12 January / Number 1 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Risk assessment group (RAG), between

Risk assessment group (RAG), between event identification and risk management. How is Belgium dealing with a crisis? Sophie Quoilin, MD SsID, 21 May 2015 Brussels Rue Juliette Wytsmanstraat 14 1050 Brussels

UPDATE ON INFECTIOUS DISEASES 2015

UPDATE ON INFECTIOUS DISEASES 2015 William Schaffner, MD Professor of Preventive Medicine, Department of Health Policy Professor of Medicine (Infectious Diseases) Vanderbilt University School of Medicine

Infectious Diseases Weekly Report. 23 August 2018 / Number 33. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 23 August / Number 33 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 8 November 2018 / Number 44. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 8 November / Number 44 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 15 November 2018 / Number 45. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 15 November / Number 45 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 14 March 2019 / Number 10. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 14 March / Number 10 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 22 March 2019 / Number 11. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 22 March / Number 11 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 28 March 2019 / Number 12. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 28 March / Number 12 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 4 April 2019 / Number 13. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 4 April / Number 13 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Infectious Diseases Weekly Report. 11 April 2019 / Number 14. The infectious diseases which all physicians must report

Infectious Diseases Weekly Report TOKYOIDWR Tokyo Metropolitan Infectious Disease Surveillance Center 11 April / Number 14 Surveillance System in Tokyo, Japan The infectious diseases which all physicians

Downloaded from

Class IX: Biology Chapter: Why do we fall ill Chapter Notes Key learnings: 1) Our body s well-being is dependent on the proper functioning of its cells and tissues. 2) All our body parts and activities

Integrating Aedes Into Existing Malaria Vector Control Systems In Africa

RBM VCWG meeting 30 Jan 1st Feb 2019 Integrating Aedes Into Existing Malaria Vector Control Systems In Africa Mamadou B. Coulibaly, PhD, PharmD University of Sciences, Techniques and Technologies of Bamako,

Objectives: To share experiences and barriers to adult vaccination in Latin American countries

Group 3 Coordinator: Dr.Roberto A. Lourenco Dr. Carlos Alberto Cano Gutiérrez - Colombia Dr. Oscar Chávez Espinosa. Nicaragua Dr. Jaime Torres. Venezuela Mr. Mark Partridge. IFA Dr. José Luis Díaz Ortega.

Prevention of arboviral diseases. Willem Takken & Sander Koenraadt Laboratory of Entomology Wageningen University and Research

Prevention of arboviral diseases Willem Takken & Sander Koenraadt Laboratory of Entomology Wageningen University and Research Brussel, 25 januari 2018 Arbivoral diseases affecting humans Mosquito borne:

Disease Prevention, Detection & Response During Public Health Emergencies

Centers for Disease Control and Prevention Disease Prevention, Detection & Response During Public Health Emergencies Tom Frieden, MD, MPH Director, Centers for Disease Control and Prevention Global Disaster

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS

Blueprint for R&D preparedness and response to public health emergencies due to highly infectious pathogens WORKSHOP ON PRIORITIZATION OF PATHOGENS 8-9 December 2015 Executive summary On 8-9 December,

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES

UNDERSTANDING ZIKA AND MOSQUITO BORNE ILLNESSES Dr. Roxanne Connelly, Professor Medical Entomology State Specialist University of Florida, IFAS, Florida Medical Entomology Laboratory http://fmel.ifas.ufl.edu/

Emerging and Re-emerging Infectious Diseases and Major Factors Contributing to their Emergence

Emerging and Re-emerging Infectious Diseases and Major Factors Contributing to their Emergence Ehsan Mostafavi; DVM, PhD Epidemiologist, Associate Professor Department of Epidemiology & Research Center

DIAGNOSTICS FOR EPIDEMIC PREPAREDNESS

DIAGNOSTICS FOR EPIDEMIC PREPAREDNESS OUTBREAK STRATEGY 2018 ABOUT FIND FIND was founded in 2003 to bridge existing development gaps for essential diagnostics by initiating and coordinating research and

The Potential Impacts of 21st Century Climatic and Population Changes on Human Exposure to the Virus Vector Mosquito Aedes aegypti

08 February 2016 The Potential Impacts of 21st Century Climatic and Population Changes on Human Exposure to the Virus Vector Mosquito Aedes aegypti A.J. Monaghan 1, K.M. Sampson 1, D.F. Steinhoff 1, K.C.

Preventing disease Promoting and protecting health

Preventing disease Promoting and protecting health CONTENTS Context Global Health Security what is it? Health security the perfect storm Regional Health Security what is it? Caribbean Regional Health Security:

Report to the Board 6-7 June 2018

6-7 June 2018 SUBJECT: VACCINE INVESTMENT STRATEGY: SHORT LIST Agenda item: 07 Category: For Decision Section A: Introduction This report presents outcomes of the Phase II analyses for the Vaccine Investment

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI

UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI OUTLINE PRESENTATION Historical perspective Vision, Mission, Core values Functions of UVRI and achievements HISTORIC PERSPECTIVE Established in 1936

Health Information For International Travel, [Paperback] By The Centers for Disease Control and Prevention - CDC

Health Information For International Travel, 2001-2002 [Paperback] By The Centers for Disease Control and Prevention - CDC If you are searched for the book by The Centers for Disease Control and Prevention

Opportunities for the Future of Healthcare and Public Health Preparedness, Response, and Recovery

Opportunities for the Future of Healthcare and Public Health Preparedness, Response, and Recovery National Academy of Medicine Workshop March 8-9, 2017 Tom Inglesby Healthcare system that can care for

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets

Inaugural Keynote Lecture: Contributions of Gavi and DCVMN to the global vaccine markets Seth Berkley M.D, CEO, Seoul www.gavi.org 1 Gavi s mission, model and achievements to date Gavi s mission Saving

Looking forward based on past experiences: What s old is new again

Looking forward based on past experiences: What s old is new again International Conference on (Re-)Emerging Infectious Diseases March 12, 2018 Rebecca Martin, PhD Director of the Center for Global Health

Preventing disease Promoting and protecting health

Preventing disease Promoting and protecting health STRENGTHENING VECTOR CONTROL FOR CHIKUNGUNYA AND DENGUE : CARPHA S ROLE Dr Christian Frederickson The problem Dengue continues to be a major public health

Demand forecasting and market considerations

Demand forecasting and market considerations New and Innovative Approaches to Laboratory Diagnosis of Zika, Dengue and other Arboviruses Workshop MAY 2 4, 2017 ANNECY Overview Introduction to UNICEF-Supply

TMSI Newsletter Taisteal CHIKUNGUNYA AN EMERGING INFECTIOUS RISK FOR TRAVELLERS Chikungunya is a Makonde word and translates as disease that bends up the joints. Chikungunya virus is an alphavirus which

CAA Meeting COMMUNICABLE DISEASE CONTROL. 20 July 2016

CAA Meeting COMMUNICABLE DISEASE CONTROL 20 July 2016 Middle East respiratory syndrome coronavirus (MERS-CoV) Globally, since September 2012, WHO has been notified of 1,782 laboratory-confirmed cases of

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a

*This response is constantly evolving and recommendations in this presentation may change over time, please call your district epidemiologist or a GDPH epidemiologist 404-657-2588, 8-5 pm M-F for current

How and Why Vaccines are Made. Stanley A. Plotkin

How and Why Vaccines are Made Stanley A. Plotkin Levine 2017 January 23, 2017 Vaccinology A combination of: Microbiology Immunology Epidemiology Public Health and Pharmacy 2 The impact of vaccination on

Public Health Image Library. CDC/ Cynthia Goldsmith. Image #

Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,

Lessons of Disease Eradication Efforts for Invasive Mussel Control. Jim Koopman MD MPH, Professor Emeritus

Lessons of Disease Eradication Efforts for Invasive Mussel Control Jim Koopman MD MPH, Professor Emeritus Talk Organization Antecedents to Smallpox Eradication philosophy Yellow fever and Malaria Smallpox,

lated at the 6 regions/zobas before emerging disease include epidemic prone diseases

Highlights: Contents Introduc on Epidemic prone disease Timeliness and completeness of the IDSR reporting at national and at zoba level is above 85%. Optimal surveillance indicators achieved for measles

A conversation with Michael Osterholm on July 30, 2013 about pandemics

A conversation with Michael Osterholm on July 30, 2013 about pandemics Participants Michael Osterholm Director, Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota Alexander

Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses

International Center for Enterprise Preparedness (InterCEP) Waiting in the Wings: Emergence, Impact and Control of Mosquito-Borne Viruses Web Forum On April 14, 2016, Kathryn A. Hanley, Professor in the

Annual Summary of Reportable Diseases Ottawa County 2017

Annual Summary of Reportable Diseases County Prepared April, James Street Holland, MI 9-9 () 9- Fax () 9- www.miottawa.org/health Table of Contents Reportable Diseases Summary Click below to go directly

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA

Confronting infectious diseases and the role of vaccination: A global perspective KATE ANTEYI. MD, MPH, MBA Technical Advisor, United States Agency for International Development (USAID) Chair, WONCA Working

Health care workers and infectious diseases

Introduction Health care workers and infectious diseases Objectives 1. What is an infectious disease?? 2. What is an infection and disease?? 3. Causes of re-emerging of the problem of the infectious diseases

Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats

Combating Agent X: Accelerating Global Vaccine Production Against New Pandemic Threats Dr. George Poste Chief Scientist, Complex Adaptive Systems Initiative and Del E. Webb Chair in Health Innovation Arizona

BOVA Network - Building Out Vector-borne diseases in sub-saharan Africa. First BOVA Open Network Meeting IEDE-UCL, London, 28 th March 2018

BOVA Network - Building Out Vector-borne diseases in sub-saharan Africa First BOVA Open Network Meeting IEDE-UCL, London, 28 th March 2018 With thanks to the Royal Society of Tropical Medicine & Hygiene

For Week 38 of 2015 (Week ending 20 September, 2015)

WEB 38 WEEKLY EPIDEMIOLOGICAL BULLETIN Ghana Health Service / Ministry of Health REPUBLIC OF GHANA For Week 38 of 2015 (Week ending 20 September, 2015) Highlights of the week: Timeliness and completeness

Mosquito Control Update. Board of County Commissioners Work Session February 16, 2016

Mosquito Control Update Board of County Commissioners Work Session February 16, 2016 1 Presentation Overview Mosquito Control Division Mosquito-borne Diseases Control Techniques Outlook 2 Mosquito Control

Zika virus infection Interim clinical guidance for Primary Care

Zika virus infection Interim clinical guidance for Primary Care Zika virus infection is a notifiable disease in Ireland under the Infectious Diseases (Amendment) Regulations 2016 (S.I.. 276 of 2016). All

Module Three About Zika Virus: What is Known and Not Known

Module Three About Zika Virus: What is Known and Not Known HOUSEKEEPING For educational and quality improvement purposes, this TeleECHO Clinic will be recorded By participating in this clinic, you are

Keynote Address: The Challenge of Achieving Universal Access to Vaccines

Keynote Address: The Challenge of Achieving Universal Access to Vaccines & AMF Seth Berkley M.D, CEO www.gavi.org 1 Vaccine landscape The world before vaccines Examples of major disease outbreaks Yellow

ZIKA VIRUS. John J. Russell MD May 27, 2016

John J. Russell MD May 27, 2016 HISTORY Discovered 1947 Zika Forest of Uganda in rhesus monkeys, thus the name Found in humans in Africa in 1952 Not considered a public health threat until outbreak in

Create the Following Chart in your notebook. Fill in as you go through each one.

Diseases of Africa Create the Following Chart in your notebook. Fill in as you go through each one. History of disease? Affected Population? How do you catch the disease? Symptoms? Prevention / Treatment?

1966 CDC assessment of US Health

Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH) Lecture 14 Emerging and New IDs Learning Objectives 1. Describe the threat of emerging and new infectious agents 2. Identify the contributing

Mercer MRC A Newsletter for and about our volunteers

Mercer MRC A Newsletter for and about our volunteers October 2017 Volume 2, Issue 2 Brian M. Hughes, County Executive Marygrace Billek, Director, Dept. of Human Services 7 Decades of Firsts the Centers

Zika Virus Update. Florida Department of Health (DOH) Mark Lander. June 16, Florida Department of Health in Columbia County

Zika Virus Update Florida Department of Health (DOH) Mark Lander June 16, 2016 Florida Department of Health in Columbia County 1 Zika Virus Originally identified in Africa and Southeast Asia First identified

SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE NATIONAL CONSENSUS MEETING 2018

SCIENTIFIC STUDY GROUP ON TRAVEL MEDICINE WETENSCHAPPELIJKE STUDIEGROEP REISGENEESKUNDE/GROUPE D'ETUDE SCIENTIFIQUE DE LA MEDECINE DES VOYAGES NATIONAL CONSENSUS MEETING 2018 Neder-over-Heembeek, October

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa

ZIKA: is South Africa at risk? Lucille Blumberg National Institute for Communicable Diseases South Africa 18 th April 1947; Rhesus macaque (no 766) with fever Filtrable transmissable agent The absence

The Zika Crisis: Where, What and USG/WHO? Brian R. Moyer BRMoyer & Associates, LLC Bedford, NH

2016 National Biotechnology Conference, Boston, May 18th The Zika Crisis: Where, What and USG/WHO? Brian R. Moyer BRMoyer & Associates, LLC Bedford, NH 03110 bmoyernh@gmail.com 2016 National Biotechnology

Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus

Aedes Zika Virus Information Sheet Town of Wolfeboro New Hampshire Health Notice Wolfeboro Public Health Officer Information Sheet Zika Virus The Zika Virus is a mosquito borne illness spread by the Aedes

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026 Dr Zabulon Yoti WHO AFRO Technical Coordinator for Health Emergencies 1 About 100 acute public health events annually

Thank you to our 2018 HHL Conference Sponsors!

1 Thank you to our 2018 HHL Conference Sponsors! GLOBAL STRATEGIES: PLANNING & RESPONDING TO PUBLIC HEALTH EMERGENCIES 3 Panel 1 11:15 12:30 Global Strategies: Planning & Responding to Public Health Emergencies

Zika Virus Infections Perspectives Past, Present and Future

Zika Virus Infections Perspectives Past, Present and Future MUSC -- April 8, 2016 Eric Brenner, MD Department of Epidemiology and Biostatistics USC School of Public Health Topics (flexibly construed) Emereging

CHAPTER AT A GLANCE. Science Class (SA-II)- IX

13 CHAPTER AT A GLANCE Health is a general condition of a preson s mind and body. According to WHO (World Health Organisation) health is a state of physical, metal and social well-being of a person. To

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared?

Emerging & re-emerging infections on the African Continent-the Public Health Aspect: Is Africa Prepared? International Conference on (Re) Emerging Infectious Diseases, 12-14 March, African Union Commission,

Global Health & Disasters Course

University of Colorado Anschutz Medical Campus September 24-28, 2018 Global Health Course Day 1: Monday, September 24, 2018 Location: Education Building 2 North, Room 1206 8:30-8:45 Course Participant

WHO Emergency Committees

WHO Emergency Committees Dr Anthony Evans Chief, Aviation Medicine Section Air Navigation Bureau aevans@icao.int +1 514 954 8150 15 July 2014 Page 1 Plan What are WHO Emergency Committees (EC)? Relation

Republic of Sierra Leone

Republic of Sierra Leone MOHS Vol. 10 Issue 18 INTEGRATED DISEASE SURVEILLANCE AND RESPONSE (IDSR) WEEKLY EPIDEMIOLOGICAL BULLETIN Highlights of the week Week 18: 01 May 07 May, 2017 All the 14 districts